Cost of stroke - A longitudinal analysis;Die kosten des schlaganfalls - Eine längsschnittanalyse

PharmacoEconomics - German Research Articles

Volumn 8, Issue 2, 2010, Pages 97-107

  Lindig, Claudia ^a   Brüggenjürgen, Bernd ^a   Willich, Stefan ^a   Reinhold, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; EMERGENCY CARE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HOSPITAL COST; HOSPITAL INFORMATION SYSTEM; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MORTALITY; STROKE;

EID: 79958034375     PISSN: 16123727     EISSN: 1868677X     Source Type: Journal    
DOI: 10.2165/11587740-000000000-00000     Document Type: Article

References (26)

1. European Commission Health and Consumer Protection Directorate-General. 2006. Age Standardised Death Rate for 65 Causes of Death; Females. ECHI, 2006. http://ec. europa.eu/health/ph-information/dissemination/echi/echi-06-en.pdf [Abgerufen am 06.10.2008]
2. Wolf P, Kannel W, d'Agostino R. Epidemiology of stroke. In: Ginsberg M, Bogousslavsky J. Cerebrovascular Disease: Pathophysiology, Diagnosis and Management.Malden, Mass: Wiley-Blackwell, 1998: 834-50
3. Rothwell PM, Coull AJ, Silver LE, et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366 (9499): 1773-83 (Pubitemid 41642641)
4. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117 (4): e25-146
5. Thom T, Haase N, Rosamund W, et al. Heart disease and stroke statistics - 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113 (6): e85-151
6. Statistisches Bundesamt. Krankheitskosten in Mio. h für Deutschland. Gliederungsmerkmale: Jahre, Alter, Geschlecht, ICD10. 2010. http://www.gbe-bund.de/oowa921- install/servlet/oowa/aw92/dboowasys921.xwdevkit/ xwd- init?gbe.isgbetol/xs-start-neu/&p-aid=i&p-aid=69205 975&nummer=553&p-sprache=D&p-indsp=-&p-aid= 54817899 [Abgerufen am 03.11.2010]
7. Kolominsky-Rabas PL, Heuschmann PU, Marschall D, et al. Lifetime cost of ischemic stroke in Germany: results and national projections froma population-based stroke registry: the Erlangen Stroke Project. Stroke 2006; 37 (5): 1179-83 (Pubitemid 43731858)
8. Aho K, Harmsen P, Hatano S, et al. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ 1980; 58 (1): 113-30 (Pubitemid 10013261)
9. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke 1996; 27 (3): 550-8
10. National Institute of Health, National Heart, Lung, and Blood Institute. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Erhältlich unter URL: http://www.nhlbi.nih.gov/resources/docs/06a-ip-chtbk. pdf [Abgerufen 05.11.10]
11. Bonita R. Epidemiology of stroke. Lancet 1992; 339 (8789): 342-4
12. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, et al. Aprospective community-based study of stroke in Germany - the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 1998; 29 (12): 2501-6 (Pubitemid 28543997)
13. Evers SM, AmentAJ, Blaauw G. Economic evaluation in stroke research: a systematic review. Stroke 2000; 31 (5): 1046-53 (Pubitemid 30253524)
14. Grieve R, Hutton J, Bhalla A, et al. A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke 2001; 32 (7): 1684-91 (Pubitemid 32631925)
15. Reed SD, Blough DK, Meyer K, et al. Inpatient costs, length of stay, and mortality for cerebrovascular events in community hospitals. Neurology 2001; 57 (2): 305-14 (Pubitemid 32667366)
16. Evers SM, Struijs JN, Ament AJ, et al. International comparison of stroke cost studies. Stroke 2004; 35 (5): 1209-15 (Pubitemid 38543545)
17. Suenkeler IH, Nowak M, Misselwitz B, et al. Timecourse of health-related quality of life as determined 3, 6 and 12 months after stroke. Relationship to neurological deficit, disability and depression. J Neurol 2002; 249 (9): 1160-7 (Pubitemid 35025088)
18. Dodel RC, Haacke C, Zamzow K, et al. Resource utilization and costs of stroke unit care in Germany. Value Health 2004; 7 (2): 144-52 (Pubitemid 38420727)
19. Krauth C, Hessel F, Hansmeier T, et al. Empirical standard costs for health economic evaluation in Germany - a proposal by the working group methods in health economic evaluation. Gesundheitswesen 2005; 67 (10): 736-46 (Pubitemid 41604934)
20. Rossnagel K, Nolte CH, Muller-Nordhorn J, et al. Medical resource use and costs of health care after acute stroke in Germany. Eur J Neurol 2005; 12 (11): 862-8 (Pubitemid 41597598)
21. Dewey HM, Thrift AG, Mihalopoulos C, et al. Cost of stroke in Australia from a societal perspective: results from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke 2001; 32 (10): 2409-16 (Pubitemid 32958558)
22. Zethraeus N, Molin T, Henriksson P, et al. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 1999; 246 (2): 151-9 (Pubitemid 29378920)
23. Kauf TL, Velazquez EJ, Crosslin DR, et al. The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. Am Heart J 2006; 151 (1): 206-12 (Pubitemid 41815357)
24. Reinhold T, Andersohn F, Hessel F, et al. The Use of Routine Data of Statutory Health Insurance (SHI) in Health Economic Research - Analysis of Applicability. Gesundheitsökonomie & Qualitätsmanagement 2010; angenommen
25. Reinhold T, Thierfelder K, Müller-Riemenschneider F, et al. Health economic effects after DRG-implementation-a systematic overview. Gesundheitswesen 2009; 71 (5): 306-12
26. McBride D, Mattenklotz AM, Willich SN, et al. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health 2009; 12 (2): 293-301